Ozempic Just Got Even More Bullish For Novo Nordisk Stock, Yet Again - The Motley Fool fool.com Submitted by motleyfool4605 on June 9, 2024 at 2:33 AM in health The market for treating chronic kidney disease is nearly within reach. No comments 40